Old Web
English
Sign In
Acemap
>
authorDetail
>
Vivian Jean M. Cline
Vivian Jean M. Cline
Texas Oncology
Brentuximab vedotin
Medicine
Internal medicine
hodgkin lymphoma
Oncology
4
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients.
2020
Journal of Clinical Oncology
Christopher A. Yasenchak
Rodolfo Bordoni
Dipti Patel-Donnelly
Timothy S. Larson
Jerome H. Goldschmidt
Ralph V. Boccia
Vivian Jean M. Cline
Andres Forero-Torres
Robert Brownell Sims
Trevor Newhook
Jonathan W. Friedberg
Show All
Source
Cite
Save
Citations (0)
Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients
2020
Blood
Christopher A. Yasenchak
Rodolfo Bordoni
Dipti Patel-Donnelly
Timothy S. Larson
Jerome H. Goldschmidt
Ralph V. Boccia
Vivian Jean M. Cline
Mariana Sacchi
Andres Forero-Torres
Robert B. Sims
Jingmin Liu
Jonathan W. Friedberg
Show All
Source
Cite
Save
Citations (3)
Long-term follow-up of brentuximab vedotin ± dacarbazine as first line therapy in elderly patients with Hodgkin lymphoma.
2018
Journal of Clinical Oncology
Jonathan W. Friedberg
Andres Forero-Torres
Beata Holkova
Jerome H. Goldschmidt
Ralph V. Boccia
Rodolfo Bordoni
Vivian Jean M. Cline
Dipti Patel-Donnelly
Patrick J. Flynn
Gregg Olsen
Robert Chen
Faith Galderisi
Yinghui Wang
Jeff Porter Sharman
Christopher A. Yasenchak
Show All
Source
Cite
Save
Citations (2)
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
2017
Blood
Jonathan W. Friedberg
Andres Forero-Torres
Rodolfo E Bordoni
Vivian Jean M. Cline
Dipti Patel-Donnelly
Patrick J. Flynn
Gregg Olsen
Robert Chen
Abraham Fong
Yinghui Wang
Christopher A. Yasenchak
Show All
Source
Cite
Save
Citations (45)
1